Article
Focal Cortical Dysplasia Type II: Somatic Mutations, Molecular Mechanisms, and Integrative Multi-Omics Framework.
CNS neuroscience & therapeutics - 1 Sept 2026
Li Zesheng, Wang Yihe, Shi Jianwei, Luo Yumin, Shan Yongzhi, Zhao Guoguang
Abstract excerpt
BACKGROUND: Focal cortical dysplasia Type II (FCD II) is a major cause of drug-resistant epilepsy in children. Somatic mosaic variants affecting the PI3K-AKT-mTOR pathway are implicated in a substantial proportion of cases. The links between genotype, cellular pathology, epileptogenic networks, and clinical outcome remain incompletely defined. METHODS: This review synthesizes evidence on somatic mTOR-pathway...
Read the complete abstract on PubMedTopics
- Humans
- Mutation
- Focal Cortical Dysplasia
- Animals
- Malformations of Cortical Development, Group I
- Multiomics
